Product Information
DIFLORASONE 0.05% OINTMENT is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.8514 per GM under NDC 64980012460. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Feb 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Rising Pharma Holdings Inc.NDC
64980012460
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DIFLORASONE DIACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA207440FDA Approved
2/27/2017
TE Code
AB
On Market Since
2/27/2017
Pharmacological Classes
Price Statistics
The NADAC for DIFLORASONE 0.05% OINTMENT has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8514 per GM |
|---|---|
| All-time high | $2.5059 (Aug 14, 2024) |
| All-time low | $0.8514 (Sep 23, 2026) |
| 52-week high | $2.0292 |
| 52-week low | $0.8514 |
| Median price | $1.5311 |
| Average price | $1.6039 |
| Largest weekly change | -31.4% (Aug 21, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diflorasone diacetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIFLORASONE 0.05% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for DIFLORASONE 0.05% OINTMENT, manufactured by Rising Pharma Holdings Inc., is $0.8514 per GM (NDC 64980012460), effective Sep 30, 2026.
How has the price of DIFLORASONE 0.05% OINTMENT changed over time?
Over the history we have for it, the NADAC for DIFLORASONE 0.05% OINTMENT has declined 64.3%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for DIFLORASONE 0.05% OINTMENT?
Since Apr 17, 2024, the NADAC for DIFLORASONE 0.05% OINTMENT has ranged from a low of $0.8514 (Sep 23, 2026) to a high of $2.5059 (Aug 14, 2024), with a median of $1.5311 per GM.
Are there cheaper alternatives to DIFLORASONE 0.05% OINTMENT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DIFLORASONE 0.05% OINTMENT in a comparable dosage form, but none are currently priced below it.
Who manufactures DIFLORASONE 0.05% OINTMENT?
DIFLORASONE 0.05% OINTMENT (NDC 64980012460) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.